Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis-Reference-Cited by-同舟云学术

Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T-cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis

Published:2014-10-13 Issue:1 Volume:34 Page:55-57
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Faguer Stanislas¹²³,Vergez François²⁴,Peres Michael²,Ferrandiz Inès¹,Casemayou Audrey³,Belliere Julie¹²³,Cointault Olivier¹,Lavayssiere Laurence¹,Nogier Marie-Béatrice¹,Prevot Grégoire⁵,Huart Antoine¹,Recher Christian²⁶,Rostaing Lionel¹²

Affiliation:

1. Département de Néphrologie et Transplantation d'organes; CHU Rangueil; Toulouse France

2. Université Paul Sabatier, Toulouse III; Toulouse France

3. Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic Disease; Toulouse France

4. Laboratoire d'Immunologie; CHU Rangueil; Toulouse France

5. Service de Pneumologie; CHU Larrey; Toulouse France

6. Service d'Hématologie; CHU Purpan; Toulouse France

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference10 articles.